{
    "2019-10-31": [
        [
            {
                "time": "2018-10-25",
                "original_text": "European agency highlights blood clot risks from Pfizer's arthritis drug",
                "features": {
                    "keywords": [
                        "blood clot",
                        "risks",
                        "Pfizer",
                        "arthritis",
                        "drug"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-10-31",
                "original_text": "Exelixis (EXEL) Q3 Earnings Beat on Strong Cabometyx Sales",
                "features": {
                    "keywords": [
                        "Exelixis",
                        "Q3",
                        "Earnings",
                        "Beat",
                        "Cabometyx",
                        "Sales"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-30",
                "original_text": "Bristol-Myers' (BMY) Q3 Earnings & Revenues Beat Estimates",
                "features": {
                    "keywords": [
                        "Bristol-Myers",
                        "Q3",
                        "Earnings",
                        "Revenues",
                        "Beat",
                        "Estimates"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-26",
                "original_text": "Glaxo (GSK) Beats Q3 Earnings Estimates, Raises '19 EPS View",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "GSK",
                        "Beats",
                        "Q3",
                        "Earnings",
                        "Raises",
                        "EPS",
                        "View"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-24",
                "original_text": "A Closer Look At Pfizer Inc.'s (NYSE:PFE) Impressive ROE",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Impressive",
                        "ROE"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-22",
                "original_text": "Small biotech Pinteon eyes large goal: a treatment for Alzheimer's",
                "features": {
                    "keywords": [
                        "Small",
                        "biotech",
                        "Pinteon",
                        "Alzheimer's",
                        "treatment"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "false"
                }
            }
        ]
    ]
}